DOI: 10.1055/s-00000030

Der Klinikarzt

References

Wildiers H, Tryfonidis K, Dal Lago L. et al.
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111–10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.

Lancet Oncol 2018;
19: 323-336

Download Bibliographical Data

Search in:
Access:
Access: